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Abstract: Due to the potential antibacterial activity of the chalcone and coumarin 
moieties, hybrid compounds containing both structures have been synthesized in good 
yield using the Knoevenagel reaction as the key step.  





Chemotherapy, in its most general sense, is the treatment of diseases by 
chemicals especially by killing micro-organisms or cancerous cells. Nowadays are 
known a wide range of different chemotherapeutic agents. In this sense, the emergence 
of multyidrug-resistance bacteria has made treatment of infectious diseases difficult. 
This means that it is necessary the discovery of novel antibacterial agents.  
One of our aims in the last years has been the development of new tools and 
methodologies for drug discovery. The molecular manipulation of promising lead 
compounds is still a major line of approach to develop new and efficient drugs. 
Following this aim we designed hybrid molecules coming from two natural occurring 
compounds: coumarin and chalcones. Coumarin derivatives have well known 
 
pharmacological activities such as antibacterial, antitumor, anti-inflammatory, 
antithrombotic, cardio protectors or enzymatic inhibitors.1-5 
Chalcones (a,-unsaturated ketones) are an important group of natural or 
synthetic flavonoids that are know to exhibit an impressive array of biological 
properties6-8. Particularly, their antimicrobial and antifungal action is attributed to the 
reactive enone moiety9. As Michael acceptor enone, reactions of chalcones are 
modulated by electron withdrawing/donating character of sustituents at the p-positions 
of the aromatic groups.  
Therefore in the present study, the chalcone functionality has been attached in a 
coumarin nucleus. The new scaffold incorporate two Michel enones in a single 
molecule and introducing different sustituents in the aromatic ring allow us to modulate 
the acceptor character for the thiol nucleophilic attack of microbial proteins.  
Using this strategy a series of 3-cinnamoylcoumarin derivatives has been 
synthesized as potential antibacterial compounds. 
 
Results and Discussion 
 
 The aim of this work has been to synthesize new coumarin-chalcone hybrids 
containing different sustituents in the aromatic rings that can potentially be used as new 
lead compounds in drug discovery, particularly as antimicrobial agents. 
 Compounds were synthesized using a two steps synthetic strategy that allows us 























Figure 1. Synthetic route used to hybrids of coumarin-chalcone. 
 
 
 The 3-acetylcoumarin precursor was prepared by a Knoevenagel reaction in 
basic conditions in 89% yield. The final step was a Claisen-Schmidt aldolic 
condensation in basic conditions that allow us to obtain the final compounds in good 
yield (Table 1) 
 











The followed methodologies in a parallel synthesis way, bring the opportunity of 
synthesize structural related compounds with punctual modifications in the aromatic 
rings depending on the starting materials. 
Biological assays as antibacterial agents will be further presented.  
 
General Experimental Procedure 
 
 All reactions were carried out under dry and deoxygenated argon atmosphere. 
Solvents were used as anhydrous by reflux of each solvent over an appropriate dryer 
agent and further distillate under argon atmosphere. 
 Qualitative identification of the compounds and course of the reactions were 
visualized using TLC plates (Merck, silica gel 60F254) under UV light (254-366 nm). 
Melting points were determined using a Reichert Kofler thermopan or in capillary tubes 
on a Büchi 510 apparatus and are uncorrected. 1H-NMR spectra were recorded on a 
Bruker WM-250 at 250 MHz using TMS as internal standard (chemical shifts in δ 
values, J in Hz). 
Synthesis of 3-acetylcoumarin: A mixture of salicilaldehyde (1 eq.), ethyl acetoacetate 
(1 eq.) and a few drops of piperidine were mixed for 5 min. at room temperature without 
Compound R2’ R4’ R5’ Yield (%) 
2 H H H 60 
3 H OMe H 61 
4 OMe OMe H 80 
5 OMe OMe OMe 50 
6 OMe NO2 H 67 
7 H H NO2 53 
 
any solvent. Reaction was neutralized with HCl (1M) and finally the product was 
isolated by filtration. The final compound was then recristalized in EtOH10.  
3-Acetylcoumarin (1): Yield 89%, Mp.: 119-121 ºC. 1H NMR (250 MHz, CDCl3) δ 
ppm 8.34 (s, 1H), 7.54 – 7.42 (m, 2H), 7.26 – 7.12 (m, 2H), 2.56 (s, 3H).  
General procedure for the synthesis of 3-cinnamoylcoumarins (2-7): A mixture of 
3-acetylcoumarin (1 eq.) and te corresponding benzaldehyde (1.2 eq.) in EtOH was 
stired with a few drops of piperidine under reflux during 2-12h. Mixture was cooled and 
the resulting solid was filtered and purified by recristalization or flash chromatography. 
Purification of compounds 2-5 was made by recristalization in MeOH, while 
compounds 6-7 were purified by flash chromatography using a 8:2 mixture of 
Hexane:AcOEt as eluent. 
3-Cinnamoylcoumarin (2): Yield 60% Mp.: 202-204 1H-NMR (250 MHz, CDCl3) δ 
ppm 8.60 (s, 1H), 7.92 (d, J = 7.9 Hz, 2H), 7.73 – 7.61 (m, 4H,), 7.45 – 7.35 (m, 5H).  
3-(4’-Methoxicinnamoyl)cumarin (3): Yield  60% Mp: 202-203 ºC. 1H NMR (250 
MHz, CDCl3) δ ppm 8.40 (s, 1H), 7.71 (d, J = 15.8 Hz, 1H), 7.62 (d, J = 15.8 Hz, 1H) 
7.48 (m, 4H), 7.29 – 7.11 (m, 2H), 6.76 (d, J = 8.8 Hz, 2H), 3.69 (s, 3H).  
3-(2’,4’-Dimethoxicinnamoyl)cumarin (4): Yield 80% Mp.:192-194ºC. 1H NMR 
(250 MHz, CDCl3) δ ppm 8.37 (s, 1H), 8.00 (d, J = 15.8 Hz, 1H), 7.72 (d, J = 15.8 Hz, 
1H), 7.56 – 7.36 (m, 3H), 7.29 – 7.11 (m, 2H), 6.36 (dd, J = 8.6, 2.2 Hz, 1H), 6.29 (d, J 
= 2.2 Hz, 1H), 3.73 (s, 3H), 3.69 (s, 3H).  
3-(2’,4’,5’-Trimethoxicinnamoyl)cumarin (5): Yield 50%. Mp: 190-192 ºC. 1H NMR 
(250 MHz, CDCl3) δ ppm 8.38 (s, 1H), 8.05 (d, J = 15.8 Hz, 1H), 7.65 (d, J = 15.8 Hz, 
1H), 7.55-7.40 (m, 2H), 7.28 – 7.12 (m, 2H), 7.01 (s, 1H), 6.33 (s, 1H), 3.78 (s, 3H), 
3.74 (s, 3H), 3.73 (s, 3H).  
3-(2’-Methoxy-4’-nitrocinnamoyl)coumarin (6): Yield 57% Mp: 227-229 ºC. 1H 
NMR (250 MHz, CDCl3) δ ppm 8.57 (s, 1H), 7.96 (d, J = 12.6 Hz 1H), 7.84-53 (m, 
5H), 7.42 (d, J = 8.8 Hz, 2H) 7. 32 (d, J = 12.6 Hz, 1H), 3.86 (s, 3H).  
3-(3’-Nitrocinnamoyl)coumarin (7): Yield 49% Mp: 205-207 ºC. . 1H NMR (250 
MHz, CDCl3) δ ppm 7,98 (d, J = 7.68 Hz 1H), 7.90 (d, J = 1.8 Hz), 7.85 (s,1H) 7.45 (t, 
J = 6.57 Hz, 2H), 7.40 – 7.30 (m, 1H), 7.28-7.17 (m, 5H).  
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